1. An 83‐year‐old patient with RET fusion‐positive non‐small cell lung cancer experiencing severe hepatic disorder due to selpercatinib administration. Issue 5 (9th April 2023) Authors: Nakashima, Kazuhisa; Mitarai, Yuki; Tanaka, Seiko; Nakao, Mika; Okuno, Takae; Okimoto, Tamio; Tanabe, Ryo; Yanagawa, Takashi; Tsubata, Yukari; Isobe, Takeshi Journal: Respirology case reports Issue: Volume 11:Issue 5(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An endobronchial hamartoma observed using narrow band imaging under saline injection: A case report. Issue 7 (26th June 2022) Authors: Kobayashi, Misato; Kurimoto, Noriaki; Mitarai, Yuki; Okuno, Takae; Nakao, Mika; Hotta, Takamasa; Hamaguchi, Megumi; Tsubata, Yukari; Isobe, Takeshi Journal: Respirology case reports Issue: Volume 10:Issue 7(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antibiotic‐induced reduction of abnormal lung shadow in pulmonary nodular lymphoid hyperplasia. Issue 2 (5th February 2020) Authors: Tanino, Akari; Tsubata, Yukari; Hamaguchi, Shunichi; Sutani, Akihisa; Nagase, Mamiko; Isobe, Takeshi Journal: Respirology case reports Issue: Volume 8:Issue 2(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Association of ABCB1 polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer. (April 2012) Authors: Hamada, Akinobu; Sasaki, Ji-ichiro; Saeki, Sho; Iwamoto, Norihiro; Inaba, Megumi; Ushijima, Sunao; Urata, Maki; Kishi, Hiroto; Fujii, Shinji; Semba, Hiroshi; Kashiwabara, Kosuke; Tsubata, Yukari; Kai, Yuki; Isobe, Takeshi; Kohrogi, Hirotsugu; Saito, Hideyuki Journal: Pharmacogenomics Issue: Volume 13:Number 5(2012) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Association of ABCB1 polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer. (April 2012) Authors: Hamada, Akinobu; Sasaki, Ji-ichiro; Saeki, Sho; Iwamoto, Norihiro; Inaba, Megumi; Ushijima, Sunao; Urata, Maki; Kishi, Hiroto; Fujii, Shinji; Semba, Hiroshi; Kashiwabara, Kosuke; Tsubata, Yukari; Kai, Yuki; Isobe, Takeshi; Kohrogi, Hirotsugu; Saito, Hideyuki Journal: Pharmacogenomics Issue: Volume 13:Number 5(2012) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Association of ABCB1 polymorphisms with erlotinib pharmacokinetics and toxicity in Japanese patients with non-small-cell lung cancer. (April 2012) Authors: Hamada, Akinobu; Sasaki, Ji-ichiro; Saeki, Sho; Iwamoto, Norihiro; Inaba, Megumi; Ushijima, Sunao; Urata, Maki; Kishi, Hiroto; Fujii, Shinji; Semba, Hiroshi; Kashiwabara, Kosuke; Tsubata, Yukari; Kai, Yuki; Isobe, Takeshi; Kohrogi, Hirotsugu; Saito, Hideyuki Journal: Pharmacogenomics Issue: Volume 13:Number 5(2012) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial. Issue 1 (January 2022) Authors: Kawashima, Yosuke; Fukuhara, Tatsuro; Saito, Haruhiro; Furuya, Naoki; Watanabe, Kana; Sugawara, Shunichi; Iwasawa, Shunichiro; Tsunezuka, Yoshio; Yamaguchi, Ou; Okada, Morihito; Yoshimori, Kozo; Nakachi, Ichiro; Seike, Masahiro; Azuma, Koichi; Kurimoto, Futoshi; Tsubata, Yukari; Fujita, Yuka; Nag... Journal: Lancet Issue: Volume 10:Issue 1(2022) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy of erlotinib and its effects on the quality of life of older patients with epidermal growth factor receptor‐mutant non‐small cell lung cancer: A prospective, multicenter, dose‐modification study. Issue 10 (10th August 2021) Authors: Tsubata, Yukari; Masuda, Takeshi; Hamai, Kosuke; Taniwaki, Masaya; Tanino, Akari; Hotta, Takamasa; Hamaguchi, Megumi; Hamaguchi, Shunichi; Yamasaki, Masahiro; Ishikawa, Nobuhisa; Fujitaka, Kazunori; Sutani, Akihisa; Isobe, Takeshi Journal: Geriatrics and gerontology international Issue: Volume 21:Issue 10(2021) Page Start: 881 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial. Issue 5 (May 2019) Authors: Saito, Haruhiro; Fukuhara, Tatsuro; Furuya, Naoki; Watanabe, Kana; Sugawara, Shunichi; Iwasawa, Shunichiro; Tsunezuka, Yoshio; Yamaguchi, Ou; Okada, Morihito; Yoshimori, Kozo; Nakachi, Ichiro; Gemma, Akihiko; Azuma, Koichi; Kurimoto, Futoshi; Tsubata, Yukari; Fujita, Yuka; Nagashima, Hiromi; Asai... Journal: Lancet oncology Issue: Volume 20:Issue 5(2019) Page Start: 625 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Exogenous lipoid pneumonia caused by herbicide inhalation. Issue 5 (6th July 2016) Authors: Hotta, Takamasa; Tsubata, Yukari; Okimoto, Tamio; Hoshino, Teppei; Hamaguchi, Shun‐ichi; Isobe, Takeshi Journal: Respirology case reports Issue: Volume 4:Issue 5(2016) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗